Ignite Creation Date:
2025-12-25 @ 2:27 AM
Ignite Modification Date:
2025-12-26 @ 1:00 AM
Study NCT ID:
NCT00248534
Status:
TERMINATED
Last Update Posted:
2018-09-04
First Post:
2005-11-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-03
First Submit QC Date:
None
Study First Post Date:
2005-11-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-10-14
Results First Submit QC Date:
None
Results First Post Date:
2018-09-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-28
Last Update Post Date:
2018-09-04
Last Update Post Date Type:
ACTUAL